Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Higher cholesterol levels increase aggressive prostate cancer risk.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Uveodermatological syndrome in dogs is hard to manage and can lead to blindness despite treatment.

Histone modification is key in treating chronic inflammatory skin diseases.

Higher IL-21 levels may help predict alopecia areata activity.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Plucked hair follicles can help diagnose scalp lupus.

Reducing IGF-1 can help rejuvenate hair follicles and prevent hair graying and loss.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

Light skin shows more inflammation from sun exposure than dark skin.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Plucking some hairs can trigger nearby unplucked hairs to grow back more due to a collective response.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.